Adiuvo Investments S.A. Stock price

Equities

ADV

PLADVIV00015

Investment Management & Fund Operators

Delayed Warsaw S.E. 12:55:41 2024-03-28 pm EDT 5-day change 1st Jan Change
0.958 PLN +4.13% Intraday chart for Adiuvo Investments S.A. +0.84% +7.64%
Sales 2021 1.6M 403K Sales 2022 449K 113K Capitalization 9.83M 2.47M
Net income 2021 -17M -4.27M Net income 2022 -55M -13.83M EV / Sales 2021 39.2 x
Net Debt 2021 30.37M 7.64M Net Debt 2022 36.37M 9.15M EV / Sales 2022 103 x
P/E ratio 2021
-1.88 x
P/E ratio 2022
-0.18 x
Employees 8
Yield 2021 *
-
Yield 2022
-
Free-Float 41.87%
More Fundamentals * Assessed data
Dynamic Chart
Adiuvo Investments S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Adiuvo Investments S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Adiuvo Investments S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Adiuvo Investments S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Adiuvo Investments S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Adiuvo Investments S.A. Auditor Raises 'Going Concern' Doubt CI
Adiuvo Investments S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Adiuvo Investments S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Adiuvo Investments S.A. Auditor Raises 'Going Concern' Doubt CI
Adiuvo Investments S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Adiuvo Investments S.A. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Adiuvo Investments S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Adiuvo Investments S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Adiuvo Investments S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Marek Orlowski, Orenore Sp. z o.o. and Morluk Sp. z o.o. sp.k. signed a preliminary agreement to acquire additional unknown stake in Adiuvo Investments S.A. from Boguslaw Bobula, Maciej Zajac and Aleksandra Siegenthaler. CI
More news
1 day+4.13%
1 week+0.84%
Current month-1.64%
1 month+1.91%
3 months+7.64%
6 months+19.45%
Current year+7.64%
More quotes
1 week
0.92
Extreme 0.92
0.96
1 month
0.91
Extreme 0.912
0.97
Current year
0.87
Extreme 0.866
1.08
1 year
0.72
Extreme 0.72
1.83
3 years
0.60
Extreme 0.6
6.24
5 years
0.60
Extreme 0.6
9.80
10 years
0.60
Extreme 0.6
32.55
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 12-12-31
Chief Operating Officer - -
Chief Tech/Sci/R&D Officer - 12-12-31
Members of the board TitleAgeSince
Director/Board Member 44 16-11-29
Director/Board Member 54 -
Director/Board Member - -
More insiders
Date Price Change Volume
24-03-28 0.958 +4.13% 786
24-03-27 0.92 -3.97% 35
24-03-26 0.958 0.00% 20
24-03-25 0.958 0.00% 20
24-03-22 0.958 +0.84% 64

Delayed Quote Warsaw S.E., March 28, 2024 at 12:55 pm EDT

More quotes
Adiuvo Investments SA is a Poland-based company engaged in the financial industry. The Company focuses on the selection, development, financing and commercialization of biomedical projects on the international market. By providing intellectual property protection, technology validation in clinical trials and obtaining certificates allowing products to market, Adiuvo Investments SA is able to commercialize projects in diverse business model and internationally. The Company is looking for and invests in projects in the segments of the nutraceutical, medical devices and the digital health. Its business portfolio encompasses Airway Medix, Algae Labs, Carocelle, Cambridge Chocolate Technology, Endomedical, Esthechoc, Glia, Joint Polish Investment Fund, Marmar Investment, Nanoxide and Peptaderm.
More about the company
  1. Stock
  2. Equities
  3. Stock Adiuvo Investments S.A. - Warsaw S.E.